Unibest

Pharmaceutical intermediates

Delgocitinib Intermediates

1 pharmaceutical intermediate for Delgocitinib. Indication: Eczema; Dermatitis; Atopic dermatitis.

提交项目All intermediates

About Delgocitinib

Originator
Leo Pharma As
Indication
Eczema; Dermatitis; Atopic dermatitis
Approved Date
07/23/2025
DS/DP
07/23/2030

Available intermediates

1 intermediate currently listed for Delgocitinib. Request specifications, documentation or a quotation for any item below.

Delgocitinib intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
1,6-Diazaspiro[3.4]octane, 3-methyl-1-(phenylmethyl)-, ethanedioate (2:1), (3S,4R)-2230683-29-9//

Other programs under D

Dabigatran EtexilateDabigatran etexilate mesylateDabrafenib MesylateDacomitinibDanicopanDapagliflozinDaridorexant HydrochlorideDarolutamide

Building toward Delgocitinib?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →